Browsing by Author Fan, Zhiping

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Showing results 1 to 17 of 17
Issue DateTitleAuthor(s)
7-Jul-2021Association Between Measurable Residual Disease in Patients With Intermediate-Risk Acute Myeloid Leukemia and First Remission, Treatment, and OutcomesYu, Sijian; Fan, Zhiping; Ma, Liping; Wang, Yu; Huang, Fen; Zhang, Qing; Huang, Jiafu; Wang, Shunqing; Xu, Na; Xuan, Li; Xiong, Mujun; Han, Lijie; Sun, Zhiqiang; Zhang, Hongyu; Liu, Hui; Yu, Guopan; Shi, Pengcheng; Xu, Jun; Wu, Meiqing; Guo, Ziwen; Xiong, Yiying; Duan, Chongyang; Sun, Jing; Liu, Qifa; Zhang, Yu
6-Dec-2021Dynamic assessment of measurable residual disease in favorable-risk acute myeloid leukemia in first remission, treatment, and outcomesYu, Sijian; Lin, Tong; Nie, Danian; Zhang, Yu; Sun, Zhiqiang; Zhang, Qing; Wang, Caixia; Xiong, Mujun; Fan, Zhiping; Huang, Fen; Xu, Na; Liu, Hui; Yu, Guopan; Zhang, Hongyu; Shi, Pengcheng; Xu, Jun; Xuan, Li; Guo, Ziwen; Wu, Meiqing; Han, Lijie; Xiong, Yiying; Sun, Jing; Wang, Yu; Liu, Qifa
2013Graft-Versus-Host Disease Following Myeloablative Busulfan Plus Fludarabine and Busulfan Plus Cyclophosphamide For Allogeneic Hematopoietic Stem Cell Transplantation In Acute Myeloid Leukemia In First Complete RemissionLiu, Qifa; Liu, Hui; Liu, Daihong; Lai, Yongrong; Sun, Jing; Song, Chaoyang; Zhang, Yu; Xiao, Yang; Huang, Fen; Zhou, Hongsheng; Fan, Zhiping; Guo, Xutao; Nie, Danian; Yu, Guopan; Huang, Xiaojun
May-2020Haploidentical transplantation might have superior graft-versus-leukemia effect than HLA-matched sibling transplantation for high-risk acute myeloid leukemia in first complete remission: a prospective multicentre cohort studyYu, Sijian; Huang, Fen; Wang, Yu; Xu, Yajing; Yang, Ting; Fan, Zhiping; Lin, Ren; Xu, Na; Xuan, Li; Ye, Jieyu; Yu, Wenjing; Sun, Jing; Huang, Xiaojun; Liu, Qifa
12-Mar-2020Haploidentical versus HLA-matched sibling transplantation for refractory acute leukemia undergoing sequential intensified conditioning followed by DLI: an analysis from two prospective dataYu, Sijian; Huang, Fen; Fan, Zhiping; Xuan, Li; Nie, Danian; Xu, Yajing; Yang, Ting; Wang, Shunqing; Jiang, Zujun; Xu, Na; Lin, Ren; Ye, Jieyu; Lin, Dongjun; Sun, Jing; Huang, Xiaojun; Wang, Yu; Liu, Qifa
23-Nov-2021The Impact of CD19 Expression Combined with Measurable Residual Disease on Post-Remission Treatment and Outcome in Adult t(8;21) Acute Myeloid LeukemiaShi, Pengcheng; Liao, Naying; Wu, Ning; Li, Huan; Huang, Fen; Xu, Na; Fan, Zhiping; Zhang, Yu; Liu, Qifa
14-Sep-2023Impact of genetic patterns on sorafenib efficacy in patients with FLT3-ITD acute myeloid leukemia undergoing allogeneic hematopoietic stem cell transplantation: a multi-center, cohort studyShao, Ruoyang; Zhang, Yu; He, Jinping; Huang, Fen; Fan, Zhiping; Yang, Kaibo; Xu, Yajing; Xu, Na; Luo, Yi; Deng, Lan; Zhang, Xi; Chen, Jia; Han, Mingzhe; Li, Xudong; Yu, Sijian; Liu, Hui; Liang, Xinquan; Luo, Xiaodan; Shi, Pengcheng; Wang, Zhixiang; Jiang, Ling; Zhou, Xuan; Lin, Ren; Chen, Yan; Tu, Sanfang; Sun, Jing; Wang, Yu; Liu, Qifa; Xuan, Li
2013Mesenchymal Stem Cells Vs. Mesenchymal Stem Cells Combined With Cord Blood For Treating Engraftment Failure Following Autologous Hematopoietic Stem Cell Transplantation: A Pilot Prospective StudyXiong, YiYing; Qian, Fan; Huang, Fen; Zhang, Yu; Wang, Yu; Chen, Xiaoyong; Fan, Zhiping; Zhou, Hongsheng; Xiao, Yang; Xu, Xiaojun; Dai, Min; Xu, Na; Sun, Jing; Xiang, Peng; Huang, Xiaojun; Liu, Qifa
2013Molecular monitoring and stepwise preemptive therapy for Epstein-Barr virus viremia after allogeneic stem cell transplantationLiu, Qifa; Xuan, Li; Liu, Hui; Huang, Fen; Zhou, Hongsheng; Fan, Zhiping; Zhao, Ke; Wu, Meiqing; Xu, Lanping; Zhai, Xiao; Zhang, Fuhua; Liu, Can; Sun, Jing; Huang, Xiaojun
2016Rituximab-based treatments followed by adoptive cellular immunotherapy for biopsy-proven EBV-associated post-transplant lymphoproliferative disease in recipients of allogeneic hematopoietic stem cell transplantationJiang, Xinmiao; Xu, Lanping; Zhang, Yu; Huang, Fen; Liu, Daihong; Sun, Jin; Song, Chaoyang; Liang, Xinquan; Fan, Zhiping; Zhou, Hongsheng; Dai, Min; Liu, Can; Jiang, Qianli; Xu, Na; Xuan, Li; Wu, Meiqing; Huang, Xiaojun; Liu, Qifa
2023Sorafenib plus triplet therapy with venetoclax, azacitidine and homoharringtonine for refractory/relapsed acute myeloid leukemia with <i>FLT3-ITD</i>: A multicenter phase 2 studyYu, Sijian; Zhang, Yu; Yu, Guopan; Wang, Yu; Shao, Ruoyang; Du, Xin; Xu, Na; Lin, Dongjun; Zhao, Weihua; Zhang, Xiong; Xiao, Jie; Sun, Zhiqiang; Deng, Lan; Liang, Xinquan; Zhang, Hongyu; Guo, Ziwen; Dai, Min; Shi, Pengcheng; Huang, Fen; Fan, Zhiping; Liu, Qiong; Lin, Ren; Jiang, Xuejie; Xuan, Li; Liu, Qifa; Jin, Hua
2019Sorafenib Therapy Is Associated with Improved Outcomes for FMS-like Tyrosine Kinase 3 Internal Tandem Duplication Acute Myeloid Leukemia Relapsing after Allogeneic Hematopoietic Stem Cell TransplantationXuan, Li; Wang, Yu; Chen, Jia; Jiang, Erlie; Gao, Li; Wu, Bingyi; Deng, Lan; Liang, Xinquan; Huang, Fen; Fan, Zhiping; Tang, Xiaowen; Sun, Jing; Zhang, Xi; Han, Mingzhe; Wu, Depei; Huang, Xiaojun; Liu, Qifa
2013Spectrum of Epstein-Barr Virus-Associated Diseases in Recipients of Allogeneic Hematopoietic Stem Cell TransplantationXuan, Li; Jiang, Xinmiao; Sun, Jing; Zhang, Yu; Huang, Fen; Fan, Zhiping; Guo, Xutao; Dai, Min; Liu, Can; Yu, Guopan; Zhang, Xian; Wu, Meiqing; Huang, Xiaojun; Liu, Qifa
2018Superior Salvage Treatment with Regimen Containing Sorafenib for Relapse of Acute Myeloid Leukemia with FLT3-ITD after Allo-HSCTXuan, Li; Wang, Yu; Chen, Jia; Jiang, Erlie; Gao, Li; Wu, Bingyi; Deng, Lan; Liang, Xinquan; Huang, Fen; Fan, Zhiping; Tang, Xiaowen; Sun, Jing; Zhang, Xi; Han, Ming-Zhe; Wu, De-Pei; Huang, Xiao Jun; Liu, Qifa
2019Two dose levels of rabbit antithymocyte globulin as graft-versus-host disease prophylaxis in haploidentical stem cell transplantation: a multicenter randomized studyLin, Ren; Wang, Yu; Huang, Fen; Fan, Zhiping; Zhang, Shen; Yang, Ting; Xu, Yajing; Xu, Na; Xu, Li; Ye, Jieyu; Sun, Jing; Huang, Xiaojun; Liu, Qifa
29-Apr-2023Venetoclax Combined with Azacitidine and Homoharringtonine in Relapsed/Refractory AML: A Multicenter, Phase 2 TrialJin, Hua; Zhang, Yu; Yu, Sijian; Du, Xin; Xu, Na; Shao, Ruoyang; Lin, Dongjun; Chen, Yanqiu; Xiao, Jie; Sun, Zhiqiang; Deng, Lan; Liang, Xinquan; Zhang, Hongyu; Guo, Ziwen; Dai, Min; Shi, Pengcheng; Huang, Fen; Fan, Zhiping; Yin, Zhao; Xuan, Li; Lin, Ren; Jiang, Xuejie; Yu, Guopan; Liu, Qifa
29-Apr-2023Venetoclax Combined with Azacitidine and Homoharringtonine in Relapsed/Refractory AML: A Multicenter, Phase 2 TrialJin, Hua; Zhang, Yu; Yu, Sijian; Du, Xin; Xu, Na; Shao, Ruoyang; Lin, Dongjun; Chen, Yanqiu; Xiao, Jie; Sun, Zhiqiang; Deng, Lan; Liang, Xinquan; Zhang, Hongyu; Guo, Ziwen; Dai, Min; Shi, Pengcheng; Huang, Fen; Fan, Zhiping; Yin, Zhao; Xuan, Li; Lin, Ren; Jiang, Xuejie; Yu, Guopan; Liu, Qifa